Related references
Note: Only part of the references are listed.PD-L1 expression in malignant salivary gland tumors
Koji Harada et al.
BMC CANCER (2018)
The expression of programed death ligand-1 could be related with unfavorable prognosis in salivary duct carcinoma
Fumihiko Sato et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2018)
The Expression of the Cancer Testis Antigen MAGE A4: A Favorable Prognostic Biomarker in Salivary Gland Carcinomas Related to Low Tumor Grading
Domenic Vital et al.
LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY (2018)
Characterization, treatment and outcomes of salivary ductal carcinoma using the National Cancer Database
Virginia Osborn et al.
ORAL ONCOLOGY (2017)
Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma
Marlen Haderlein et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2017)
Immunohistochemical investigations on the expression of programmed cell death ligand 1, human leukocyte antigens G and E, and granzyme B in intraoral mucoepidermoid carcinoma
Carla Mosconi et al.
ARCHIVES OF ORAL BIOLOGY (2017)
The pattern and clinicopathological correlates of programmed death-ligand 1 expression in cutaneous squamous cell carcinoma
K. Schaper et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Current events in immunotherapy for upper aerodigestive tract cancer
Sophie Outh-Gauer et al.
ANNALES DE PATHOLOGIE (2017)
Clinical Outcomes and Prognostic Factors for Salivary Duct Carcinoma: A Multi-Institutional Analysis of 141 Patients
Kuninori Otsuka et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas
Ashley Cimino-Mathews et al.
HUMAN PATHOLOGY (2016)
PD-L1 expression is regulated by hypoxia inducible factor in clear cell renal cell carcinoma
Melanie Ruf et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
PD-L1 expression in cutaneous squamous cell carcinoma correlates with risk of metastasis
Nathaniel A. Slater et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2016)
Cytogenetic and immunohistochemical biomarker profiling of therapy-relevant factors in salivary gland carcinomas
Juliana Lemound et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2016)
Clinicopathological features and treatment outcomes of the rare, salivary duct carcinoma of parotid gland
Khalid Hussain AL-Qahtani et al.
JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2016)
Programmed Death Ligand-1 Expression Is Associated With Poor Disease Free Survival in Salivary Gland Carcinomas
Takashi Mukaigawa et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
Salivary Duct Carcinoma of the Parotid: Outcomes with a Contemporary Multidisciplinary Treatment Approach
Matthew Mifsud et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2016)
Predictive PD-L1 immunohistochemistry for non-small cell lung cancer. Current state of the art and experiences of the first German harmonization study
A. H. Scheel et al.
PATHOLOGE (2016)
Association between PD-L1 and HPV Status and the Prognostic Value of PD-L1 in Oropharyngeal Squamous Cell Carcinoma
Hae Su Kim et al.
CANCER RESEARCH AND TREATMENT (2016)
Immune Profiling of Adenoid Cystic Carcinoma: PD-L2 Expression and Associations with Tumor-Infiltrating Lymphocytes
Vishwajith Sridharan et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Suzanne L. Topalian et al.
NATURE REVIEWS CANCER (2016)
Prognostic factors and oncologic outcomes of 56 salivary duct carcinoma patients in a single institution: High rate of systemic failure warrants targeted therapy
Jong-Lyel Roh et al.
ORAL ONCOLOGY (2014)
The role of the PD-L1: PD-1 pathway in squamous cell carcinoma of the head and neck
Dan P. Zandberg et al.
ORAL ONCOLOGY (2014)
PD-1 Pathway Inhibitors: Changing the Landscape of Cancer Immunotherapy
Dawn E. Dolan et al.
CANCER CONTROL (2014)
PD-L1 Expression in Triple-Negative Breast Cancer
Elizabeth A. Mittendorf et al.
CANCER IMMUNOLOGY RESEARCH (2014)
PD-1-Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer
Cecile Badoual et al.
CANCER RESEARCH (2013)
Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinoma
Sofia Lyford-Pike et al.
CANCER RESEARCH (2013)
PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival
Evan J. Lipson et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
Janis M. Taube et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review
Scott A. Laurie et al.
LANCET ONCOLOGY (2011)
The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: Correlation with important high-risk prognostic factors
Hazem Ghebeh et al.
NEOPLASIA (2006)
Co-inhibitory role of T-cell-associated B7-H1 and B7-DC in the T-cell immune response
SK Seo et al.
IMMUNOLOGY LETTERS (2006)
Clinical and immunohistologic typing of salivary duct carcinoma -: A report of 50 cases
M Jaehne et al.
CANCER (2005)
Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer
Y Ohigashi et al.
CLINICAL CANCER RESEARCH (2005)
The role of radiotherapy in the treatment of malignant salivary gland tumors
CHJ Terhaard et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
B7-H1 pathway and its role in the evasion of tumor immunity
HD Dong et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2003)
Salivary duct carcinoma: immunohistochemical profile of an aggressive salivary gland tumour
A Etges et al.
JOURNAL OF CLINICAL PATHOLOGY (2003)
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Y Iwai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Salivary gland tumours
PM Speight et al.
ORAL DISEASES (2002)
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
HD Dong et al.
NATURE MEDICINE (2002)
Share Paper
